JP2009528354A5 - - Google Patents

Download PDF

Info

Publication number
JP2009528354A5
JP2009528354A5 JP2008557304A JP2008557304A JP2009528354A5 JP 2009528354 A5 JP2009528354 A5 JP 2009528354A5 JP 2008557304 A JP2008557304 A JP 2008557304A JP 2008557304 A JP2008557304 A JP 2008557304A JP 2009528354 A5 JP2009528354 A5 JP 2009528354A5
Authority
JP
Japan
Prior art keywords
amino
phenyl
benzamide
oxoethyl
thienyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008557304A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009528354A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/004724 external-priority patent/WO2007100657A2/en
Publication of JP2009528354A publication Critical patent/JP2009528354A/ja
Publication of JP2009528354A5 publication Critical patent/JP2009528354A5/ja
Withdrawn legal-status Critical Current

Links

JP2008557304A 2006-02-28 2007-02-23 ヒストン脱アセチル化酵素のインヒビター Withdrawn JP2009528354A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77771406P 2006-02-28 2006-02-28
PCT/US2007/004724 WO2007100657A2 (en) 2006-02-28 2007-02-23 Inhibitors of histone deacetylase

Publications (2)

Publication Number Publication Date
JP2009528354A JP2009528354A (ja) 2009-08-06
JP2009528354A5 true JP2009528354A5 (enExample) 2009-09-24

Family

ID=38459567

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008557304A Withdrawn JP2009528354A (ja) 2006-02-28 2007-02-23 ヒストン脱アセチル化酵素のインヒビター

Country Status (6)

Country Link
US (1) US8168658B2 (enExample)
EP (1) EP1991226B1 (enExample)
JP (1) JP2009528354A (enExample)
AU (1) AU2007221207A1 (enExample)
CA (1) CA2642813A1 (enExample)
WO (1) WO2007100657A2 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005070020A2 (en) 2004-01-23 2005-08-04 The Regents Of The University Of Colorado Gefitinib sensitivity-related gene expression and products and methods related thereto
ES2537631T3 (es) 2004-05-27 2015-06-10 The Regents Of The University Of Colorado Métodos para la predicción del resultado clínico para inhibidores del receptor del factor de crecimiento epidérmico para pacientes de cáncer
CN101808518A (zh) * 2007-06-27 2010-08-18 默沙东公司 作为组蛋白脱乙酰酶抑制剂的吡啶基和嘧啶基衍生物
EP3103791B1 (en) 2007-06-27 2018-01-31 Merck Sharp & Dohme Corp. 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
WO2009095324A1 (en) * 2008-01-29 2009-08-06 F. Hoffmann-La Roche Ag Novel n-(2-amino-phenyl)-amide derivatives
AU2009228931B2 (en) 2008-03-27 2013-05-23 Janssen Pharmaceutica Nv Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase
MX2010012297A (es) 2008-05-16 2010-12-06 Hoffmann La Roche Nuevas n-(2-amino-fenil)-acrilamidas.
PL2292611T3 (pl) 2008-05-23 2012-11-30 Santen Pharmaceutical Co Ltd Nowa pochodna tiofenodiaminy mająca strukturę mocznikową
WO2010028192A1 (en) * 2008-09-03 2010-03-11 Repligen Corporation Compositions including 6-aminohexanoic acid derivatives as hdac inhibitors
US8202866B2 (en) * 2008-09-17 2012-06-19 Hoffmann-La Roche Inc. Ortho-aminoanilides for the treatment of cancer
JP2012518612A (ja) 2009-02-23 2012-08-16 エフ.ホフマン−ラ ロシュ アーゲー ガンの治療のための新規なオルトアミノアミド類
NZ599757A (en) 2009-10-30 2014-08-29 Massachusetts Inst Technology The use of ci-994 and dinaline for the treatment of memory/cognition and anxiety disorders
US8546588B2 (en) 2010-02-26 2013-10-01 Millennium Pharmaceuticals, Inc. Substituted hydroxamic acids and uses thereof
US8957066B2 (en) 2011-02-28 2015-02-17 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US10059723B2 (en) 2011-02-28 2018-08-28 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
US9540395B2 (en) 2011-02-28 2017-01-10 Biomarin Pharmaceutical Inc. Histone deacetylase inhibitors
WO2013016193A2 (en) 2011-07-22 2013-01-31 Massachusetts Istitute Of Technology Activators of class i histone deacetlyases (hdacs) and uses thereof
RU2665554C2 (ru) 2013-03-15 2018-08-31 Байомарин Фармасьютикал Инк. Ингибиторы hdac
CN103880842B (zh) * 2014-02-20 2016-04-13 南通大学 具HDAC抑制活性的β-咔啉类衍生物及制备方法和用途
CN103880841B (zh) * 2014-02-20 2016-04-13 南通大学 含有β-咔啉-3-酰亚肼基的HDAC抑制剂及其制备方法和用途
KR20250004174A (ko) 2014-06-27 2025-01-07 노그라 파마 리미티드 아릴 수용체 조정제, 및 그의 제조 및 사용 방법
WO2016109501A1 (en) * 2014-12-30 2016-07-07 Karos Pharmaceuticals, Inc. Amide compounds as tryptophan hydroxylase inhibitors
EP3856174A4 (en) * 2018-09-25 2022-09-28 Regenacy Pharmaceuticals, Inc. HDAC1, 2 INHIBITORS

Family Cites Families (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3324115A1 (de) * 1983-07-05 1985-01-17 Dr. Karl Thomae Gmbh, 7950 Biberach Neue imidazole, ihre herstellung und diese verbindungen enthaltende arzneimittel
DE3505609A1 (de) * 1985-02-19 1986-08-21 Merck Patent Gmbh, 6100 Darmstadt Benzimidazolyl-pyridazinone
US5700811A (en) * 1991-10-04 1997-12-23 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and method of use thereof
US5369108A (en) * 1991-10-04 1994-11-29 Sloan-Kettering Institute For Cancer Research Potent inducers of terminal differentiation and methods of use thereof
US6069143A (en) * 1994-12-20 2000-05-30 Smithkline Beecham Corporation Fibrinogen receptor antagonists
JP2000514427A (ja) 1996-06-28 2000-10-31 メルク エンド カンパニー インコーポレーテッド フィブリノーゲンレセプター拮抗薬プロドラッグ
US6174905B1 (en) * 1996-09-30 2001-01-16 Mitsui Chemicals, Inc. Cell differentiation inducer
PH11998001072B1 (en) 1997-05-07 2006-11-21 Univ Pittsburgh Inhibitors of protein isoprenyl transferases
US6506783B1 (en) * 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
JP4405602B2 (ja) 1998-04-16 2010-01-27 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト ヒストン脱アセチル化酵素阻害剤
AU3665199A (en) 1998-04-29 1999-11-16 Vertex Pharmaceuticals Incorporated Inhibitors of impdh enzyme
JPH11335375A (ja) 1998-05-20 1999-12-07 Mitsui Chem Inc ヒストン脱アセチル化酵素阻害作用を有するベンズアミド誘導体
FR2783519B1 (fr) * 1998-09-23 2003-01-24 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
US6653309B1 (en) * 1999-04-26 2003-11-25 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme technical field of the invention
CA2374793A1 (en) 1999-05-24 2000-11-30 Penglie Zhang Inhibitors of factor xa
HUP0202707A3 (en) * 1999-09-08 2003-11-28 Univ Columbia Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and pharmaceutical compositions containing them and use thereof
WO2001030780A2 (en) 1999-10-27 2001-05-03 Cor Therapeutics, Inc. Pyridyl-containing spirocyclic compounds as inhibitors of fibrinogen-dependent platelet aggregation
JP4360660B2 (ja) 1999-11-09 2009-11-11 三井化学株式会社 モノアシルフェニレンジアミン誘導体の精製法
WO2001038322A1 (en) 1999-11-23 2001-05-31 Methylgene, Inc. Inhibitors of histone deacetylase
ES2293980T3 (es) 2000-01-13 2008-04-01 Amgen Inc. Agentes antibacterianos.
ATE311366T1 (de) 2000-02-29 2005-12-15 Millennium Pharm Inc Benzamide und ähnliche inhibitoren vom faktor xa
AU2001268711A1 (en) 2000-06-23 2002-01-08 Bristol-Myers Squibb Pharma Company Heteroaryl-phenyl substituted factor xa inhibitors
US6849660B1 (en) 2000-08-01 2005-02-01 Isis Pharmaceuticals, Inc. Antimicrobial biaryl compounds
CN1291988C (zh) 2001-03-19 2006-12-27 小野药品工业株式会社 三氮杂螺[5,5]十一烷衍生物及包含其作为活性成分的药物组合物
TWI239942B (en) 2001-06-11 2005-09-21 Dainippon Pharmaceutical Co N-arylphenylacetamide derivative and pharmaceutical composition containing the same
WO2003004488A1 (en) * 2001-07-03 2003-01-16 Chiron Corporation Indazole benzimidazole compounds as tyrosine and serine/threonine kinase inhibitors
SE0102439D0 (sv) 2001-07-05 2001-07-05 Astrazeneca Ab New compounds
AR034897A1 (es) * 2001-08-07 2004-03-24 Hoffmann La Roche Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos
US6897220B2 (en) * 2001-09-14 2005-05-24 Methylgene, Inc. Inhibitors of histone deacetylase
US7868204B2 (en) * 2001-09-14 2011-01-11 Methylgene Inc. Inhibitors of histone deacetylase
KR20100107509A (ko) 2001-09-14 2010-10-05 9222-9129 퀘벡 인코포레이티드 히스톤 데아세틸라아제의 억제제
ATE395343T1 (de) 2002-03-13 2008-05-15 Janssen Pharmaceutica Nv Sulfonylderivate als histone-deacetylase- inhibitoren
EP1485348B1 (en) 2002-03-13 2008-06-11 Janssen Pharmaceutica N.V. Carbonylamino-derivatives as novel inhibitors of histone deacetylase
US7501417B2 (en) 2002-03-13 2009-03-10 Janssen Pharmaceutica, N.V. Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
TWI319387B (en) 2002-04-05 2010-01-11 Astrazeneca Ab Benzamide derivatives
GB0209715D0 (en) 2002-04-27 2002-06-05 Astrazeneca Ab Chemical compounds
CN1703395A (zh) * 2002-08-09 2005-11-30 特兰斯泰克制药公司 芳基和杂芳基化合物以及调节凝血的方法
CN1688577A (zh) 2002-09-18 2005-10-26 小野药品工业株式会社 三氮杂螺[5.5]十一烷衍生物及以它为活性成分的药物
AU2003266607A1 (en) 2002-09-25 2004-04-19 Santen Pharmaceutical Co., Ltd. Therapeutic agent for rheumatism containing benzamide derivative as active ingredient
KR20050074487A (ko) 2002-10-17 2005-07-18 메틸진, 인크. 히스톤 데아세틸라아제의 억제제
TW200426138A (en) * 2002-12-10 2004-12-01 Hoffmann La Roche Novel arylene-carboxylic acid (2-amino-phenyl)-amide derivatives, their manufacture and use as pharmaceutical agents
WO2004058234A2 (en) 2002-12-27 2004-07-15 Schering Aktiengesellschaft Pharmaceutical combinations of phthalazine vegf inhibitors and benzamide hdac inhibitors
EP1608628A2 (en) * 2003-03-17 2005-12-28 Takeda San Diego, Inc. Histone deacetylase inhibitors
AR043633A1 (es) * 2003-03-20 2005-08-03 Schering Corp Ligandos de receptores de canabinoides
US7488739B2 (en) 2003-07-24 2009-02-10 Astellas Pharma Inc. Quinolone derivative or salt thereof
EP1663953A1 (en) 2003-09-24 2006-06-07 Methylgene, Inc. Inhibitors of histone deacetylase
WO2005053609A2 (en) 2003-11-26 2005-06-16 Guilford Pharmaceuticals Inc. Methods of nad+-dependent deacetylase inhibitors
MXPA06010900A (es) 2004-03-26 2007-02-21 Methylgene Inc Inhibidores de histona desacetilasa.
AU2005257859A1 (en) 2004-05-21 2006-01-05 Merck & Co., Inc. Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
US20080234254A1 (en) 2004-06-10 2008-09-25 University Of Leeds Inhibitors of Histone Deacetylase
US7745446B2 (en) 2004-09-06 2010-06-29 Bayer Schering Pharma Aktiengesellschaft Pyrazolo[1,5-c]pyrimidines
JP2008536926A (ja) * 2005-04-20 2008-09-11 メルク エンド カムパニー インコーポレーテッド ベンゾチオフェン誘導体
US8158825B2 (en) * 2005-06-24 2012-04-17 Merck Sharp & Dohme Corp. Modified malonate derivatives
EP1945028A4 (en) * 2005-11-03 2011-01-19 Merck Sharp & Dohme SUBSTITUTED NICOTINAMIDE COMPOUNDS
WO2007087130A2 (en) * 2006-01-12 2007-08-02 Merck & Co., Inc. Hydroxyalkylarylamide derivatives
US20090012075A1 (en) 2006-01-12 2009-01-08 Miller Thomas A Fluorinated Arylamide Derivatives
CN101466670B (zh) 2006-04-07 2013-04-17 梅特希尔基因公司 组蛋白脱乙酰酶抑制剂
AU2007243519A1 (en) * 2006-04-26 2007-11-08 Merck Sharp & Dohme Corp. Disubstituted aniline compounds
EP2049124A4 (en) 2006-07-20 2010-02-10 Merck & Co Inc PHOSPHOR DERIVATIVES AS HISTONDEACETYLASE HEMMER
CN101808518A (zh) * 2007-06-27 2010-08-18 默沙东公司 作为组蛋白脱乙酰酶抑制剂的吡啶基和嘧啶基衍生物

Similar Documents

Publication Publication Date Title
JP2009528354A5 (enExample)
JP2008502700A5 (enExample)
JP2015517981A5 (enExample)
RU2361860C2 (ru) Новые замещенные 3-сера-индолы
JP2004508304A5 (enExample)
JP2015509543A5 (enExample)
JP2994546B2 (ja) スルファモイル基およびアミジノ基を有する化合物および製造方法
JP2007519754A5 (enExample)
JP2014511869A5 (enExample)
HRP20160537T1 (hr) Modulatori indolamina 2,3-dioksigenaze i metode za upotrebu istih
JP2005510500A5 (enExample)
HRP20140970T1 (hr) Spoj azolkarboksamida ili njegova sol
RU2004129780A (ru) Производные аминоиндазолов, способ получения и промежуточные продукты этого способа в качестве лекарственных средств и содержащие их фармацевтические композиции
JP2011518774A5 (enExample)
CA2690226A1 (en) Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
JP2011524906A5 (enExample)
HRP20141048T1 (hr) Spojevi, pripravci i metode
JP2010523644A5 (enExample)
RU2007101073A (ru) Пятичленные гетероциклы, применимые в качестве ингибиторов сериновой протеазы
CA2436526A1 (en) Heterocyclic sulfonamide inhibitors of beta amyloid production
JP2016512193A5 (enExample)
JP2013512899A5 (enExample)
RU2009118254A (ru) Фенилацетамиды в качестве ингибиторов протеинкиназ
JP2010505881A5 (enExample)
JP2013517273A5 (enExample)